Pharmacology IV MD0807

DEVELOPMENT
ADMINISTRATION
TABLE OF CONTENTS
INTRODUCTION
LESSON 1
	Section I. INTRODUCTION
		1-1. GENERAL
		1-2. FOODS AND FOODSTUFFS
	Section II. THE SUPRAGASTRIC STRUCTURES
		1-3. ORAL COMPLEX
		1-4. PHARYNX
		1-5. ESOPHAGUS
	Section III. THE STOMACH
		1-6. STORAGE FUNCTION
		1-7. DIGESTIVE FUNCTION
	Section IV. THE SMALL INTESTINES AND ASSOCIATED GLANDS
		1-8. GENERAL
		1-9. ANATOMY OF THE SMALL INTESTINES
	Section V. THE LARGE INTESTINES
		1-10. GENERAL FUNCTION
		1-11. MAJOR SUBDIVISIONS
		1-12. RECTUM, ANAL CANAL, AND ANUS
	Section VI. ASSOCIATED PROTECTIVE STRUCTURES
		1-13. GENERAL
		1-14. STRUCTURES WITHIN THE DIGESTIVE SYSTEM
	Section VII. ACCESSORY STRUCTURES OF THE DIGESTIVE SYSTEM
		1-15. THE LIVER
		1-16. THE PANCREAS
	Section VIII. ABSORPTION AND METABOLISM IN THE DIGESTIVE SYSTEM
		1-17. INTRODUCTION
		1-18. THE DIGESTION OF CARBOHYDRATES
		1-19. THE DIGESTION OF FAT
		1-20. THE DIGESTION OF PROTEINS
	Section IX. DISORDERS AND DISEASES OF THE DIGESTIVE TRACT
		1-21. INTRODUCTION
		1-22. DISORDERS OF THE MOUTH CAVITY
		1-23. DISORDERS OF THE STOMACH
		1-24. DISORDERS OF THE INTESTINES
	EXERCISES
	SOLUTIONS
LESSON 2
	Section I. ANTACIDS
		2-1. INTRODUCTION
		2-2. GENERAL CONSIDERATIONS FOR ANTACIDS
		2-3. ANTACID PREPARATIONS
	Section II. DIGESTANTS
		2-4. DEFINITION
		2-5. INDICATION OF DIGESTANT THERAPY
		2-6. EXAMPLES OF DIGESTANTS
	EXERCISES
	SOLUTIONS
LESSON 3
	Section I. OVERVIEW
		3-1. INTRODUCTION
		3-2. DEFINITIONS
	Section II. EMETICS
		3-3. INTRODUCTION
		3-4. EXAMPLES OF EMETIC AGENTS
	Section III. ANTIEMETICS
		3-5. INTRODUCTION/INDICATIONS FOR ANTIEMETIC THERAPY
		3-6. EXAMPLES OF ANTIEMETICS
	Section IV. ANTIDIARRHEALS
		3-7. INTRODUCTION
		3-8. EXAMPLES OF ANTIDIARRHEAL AGENTS
	EXERCISES
	SOLUTIONS
LESSON 4
	Section I. INTRODUCTION
		4-1. OVERVIEW
		4-2. DEFINITION OF A CATHARTIC
		4-3. THE CATHARTIC (LAXATIVE) HABIT
		4-4. THE NORMAL FUNCTIONING OF THE BOWELS
		4-5. FACTORS WHICH HELP TO MAINTAIN NORMAL BOWEL HABITS
		4-6. PRECAUTIONS ASSOCIATED WITH THE USE OF CATHARTICS
	Section II. CATHARTIC AGENTS
		4-7. INTRODUCTION
		4-8. IMPORTANT INFORMATION FOR PERSONS TAKING CATHARTICS
		4-9. MECHANISMS OF ACTION OF CATHARTICS
		4-10. CATEGORIES AND SPECIFIC EXAMPLES OF CATHARTICS
	EXERCISES
	SOLUTIONS
LESSON 5
	Section I. INTRODUCTION TO FLUID AND ELECTROLYTE PHYSIOLOGY
	Section II. PRECAUTIONS AND COMPLICATIONS ASSOCIATED
		5-1. INTRODUCTION
		5-2. TWO BASIC CATEGORIES OF INTRAVENOUS PREPARATIONS
		5-3. REQUIREMENTS FOR INTRAVENOUS SOLUTIONS/INTRAVENOUS
		5-4. PRECAUTIONS PERTAINING TO FLUID THERAPY
		5-5. COMPLICATIONS OF INTRAVENOUS FLUID THERAPY
	Section III. CATEGORIES OF INTRAVENOUS FLUIDS AND THEIR USES
		5-6. INTRODUCTION
		5-7. HYDRATING SOLUTIONS
		5-8. ELECTROLYTE REPLACEMENT SOLUTIONS
		5-9. PLASMA EXPANDERS
		5-10. NUTRIENT SOLUTIONS (HYPERALIMENTATION PRODUCTS)
	EXERCISES
	SOLUTIONS
LESSON 6
	Section I. INTRODUCTION
		6-1. OVERVIEW
		6-2. BASIC DEFINITIONS
		6-3. GENERAL COMMENTS
	Section II. ENDOCRINE GLANDS
		6-4. INTRODUCTION
		6-5. THE PITUITARY BODY
		6-6. THE POSTERIOR PITUITARY GLAND
		6-7. THE ANTERIOR PITUITARY GLAND
		6-8. THE THYROID GLAND
		6-9. THE PARATHYROID GLANDS
		6-10. THE ADRENAL GLANDS
		6-11. THE PANCREAS
		6-12. THE GONADS
		6-13. THE FEMALE’S MENSTRUAL CYCLE
		6-14. CHANGES DUE TO FERTILIZATION OF THE OVUM
		6-15. MENOPAUSE
	Section III. DISORDERS OF THE HUMAN REPRODUCTIVE SYSTEM
		6-16. INTRODUCTION
		6-17. ECTOPIC PREGNANCY
		6-18. TOXEMIA OF PREGNANCY
	EXERCISES
	SOLUTIONS
LESSON 7
	Section I. OVERVIEW
		7-1. INTRODUCTION
		7-2. THE NATURAL THYROID HORMONES
		7-3. FUNCTION OF THE THYROID HORMONES
		7-4. HYPOTHYROIDISM
		7-5. HYPERTHYROIDISM
	Section II. THYROID PREPARATIONS
		7-6. PRECAUTIONS FOR PATIENTS WHO ARE TAKING THYROID
		7-7. THYROID PREPARATIONS
		7-8. MISCELLANEOUS PREPARATION
	Section III. ANTITHYROID PREPARATIONS
		7-9. INTRODUCTION AND INDICATIONS
		7-10. ANTITHYROID PREPARATIONS
	Section IV. PARATHYROID PREPARATIONS
		7-11. INTRODUCTION AND INDICATION FOR USE
		7-12. PARATHYROID PREPARATIONS
	EXERCISES
	SOLUTIONS
LESSON 8
	Section I. INTRODUCTION
		8-1. GENERAL COMMENTS
		8-2. REPRODUCTIVE HORMONES
	Section II. USES OF REPRODUCTIVE HORMONES
		8-3. INTRODUCTION
		8-4. USES OF ESTROGEN
		8-5. SIDE EFFECTS ASSOCIATED WITH ESTROGEN THERAPY
		8-6. USES OF PROGESTINS
		8-7. SIDE EFFECTS ASSOCIATED WITH PROGESTIN THERAPY
		8-8. PRECAUTIONS ASSOCIATED WITH THE USE OF PROGESTINS
		8-9. USES OF ANDROGEN THERAPY
		8-10. SIDE EFFECTS ASSOCIATED WITH ANDROGEN THERAPY
	Section III. SPECIFIC REPRODUCTIVE HORMONES
		8-11. INTRODUCTION
		8-12. SPECIFIC ESTROGEN AGENTS
		8-13. SPECIFIC PROGESTIN AGENTS
		8-14. SPECIFIC ANDROGEN AGENTS
	Section IV. CONTRACEPTION
		8-15. INTRODUCTION
		8-16. METHODS OF CONTRACEPTION
		8-17. GENERAL DIRECTIONS FOR TAKING ORAL CONTRACEPTIVES
		8-18. GOAL OF CONTRACEPTIVE THERAPY
		8-19. EXAMPLES OF ORAL CONTRACEPTIVES BY TYPE
		8-20. PRECAUTIONARY STATEMENT
	Section V. OVULATION INDUCING AGENT
		8-21. INTRODUCTION
		8-22. CLOMIPHENE CITRATE (CLOMID®), AN OVULATION INDUCING AGENT
	EXERCISES
	SOLUTIONS
LESSON 9
	Section I. OVERVIEW
		9-1. INTRODUCTION
		9-2. THE ADRENAL GLANDS (SUPRARENAL GLANDS) AND THEIR PRODUCTS
		9-3. HORMONES PRODUCED BY THE CORTEX OF THE ADRENAL GLANDS
		9-4. THE MINERALOCORTICOIDS
		9-5. THE GLUCOCORTICOIDS (HYDROCORTISONE (CORTISOL) AND OTHERS)
		9-6. ABNORMALITIES OF ADRENAL FUNCTIONING
	Section II. GLUCOCORTICOIDS AND SYNTHETIC AGENTS
		9-7. INTRODUCTION
		9-8. ADRENOCORTICAL SUPPRESSION WITH GLUCOCORTICOID AGENTS
		9-9. CLINICAL INDICATIONS FOR GLUCOCORTICOIDS
		9-10. ADVERSE EFFECTS ASSOCIATED WITH GLUCOCORTICOID THERAPY
		9-11. CAUTIONS AND WARNINGS ASSOCIATED WITH GLUCOCORTICOID
		9-12. GLUCOCORTICOID PREPARATIONS
		9-13. TOPICAL PREPARATIONS
		9-14. RELATIVE POTENCIES OF SYSTEMIC ADRENOCORTICAL STERIODS
	EXERCISES
	SOLUTIONS
LESSON 10
	Section I. PHYSIOLOGY OF INSULIN
		10-1. INTRODUCTION
		10-2. HISTORY OF INSULIN
		10-3. THE CHEMICAL INSULIN
		10-4. ACTIONS OF INSULIN
		10-5. PRODUCTION OF INSULIN IN THE BODY
		10-6. CONDITIONS DUE TO ABNORMAL AMOUNTS OF INSULIN IN THE
	Section II. CONDITIONS DUE TO ABNORMAL AMOUNTS
		10-7. DIABETES MELLITUS
		10-8. TYPES OF DIABETES MELLITUS
	Section III. TREATMENT OF DIABETES MELLITUS BY INSULIN THERAPY
		10-9. INTRODUCTION
		10-10. SOURCES OF INSULIN
		10-11. MEASUREMENT OF INSULIN
		10-12. USE OF INSULIN PREPARATIONS
		10-13. STORAGE OF INSULIN PREPARATIONS
		10-14. INSULIN SYRINGES
		10-15. MIXING OF INSULIN TYPES
		10-16. TYPES OF INSULIN
		10-17. IRREGULARITIES OF INSULIN THERAPY
	Section IV. ORAL HYPOGLYCEMIC AGENTS
		10-18. INTRODUCTION
		10-19. MECHANISM OF ACTION OF ORAL HYPOGLYCEMIC AGENTS
		10-20. POSSIBLE DRUG INTERACTIONS
		10-21. DOSING INFORMATION
		10-22. SPECIFIC ORAL HYPOGLYCEMIC AGENTS
	EXERCISES
	SOLUTIONS
LESSON 11
	Section I. OXYTOCICS
		11-1. INTRODUCTION
		11-2. THE PROCESS OF BIRTH
		11-3. ACTION OF OXYTOCIN
		11-4. ROLE OF OXYTOCIN IN THE BIRTH PROCESS
		11-5. THE STAGES OF LABOR
		11-6. USES OF OXYTOCIN
		11-7. NOTE CONCERNING USE OF MORE THAN ONE OXYTOCIC AGENT AT
		11-8. UTERINE STIMULANTS
	Section II. ERGOT ALKALOIDS
		11-9. INTRODUCTION
		11-10. USES OF THE ERGOT ALKALOIDS
		11-11. ERGOTISM
		11-12. SPECIFIC ERGOT AGENTS
		11-13. CONTRAINDICATIONS FOR OXYTOCICS AND ERGOT ALKALOID
	EXERCISES
	SOLUTIONS